130 related articles for article (PubMed ID: 20307591)
1. Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies.
Jegerlehner A; Wiesel M; Dietmeier K; Zabel F; Gatto D; Saudan P; Bachmann MF
Vaccine; 2010 Jul; 28(33):5503-12. PubMed ID: 20307591
[TBL] [Abstract][Full Text] [Related]
2. Versatile RHDV virus-like particles: incorporation of antigens by genetic modification and chemical conjugation.
Peacey M; Wilson S; Baird MA; Ward VK
Biotechnol Bioeng; 2007 Dec; 98(5):968-77. PubMed ID: 17546687
[TBL] [Abstract][Full Text] [Related]
3. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.
Chackerian B; Rangel M; Hunter Z; Peabody DS
Vaccine; 2006 Sep; 24(37-39):6321-31. PubMed ID: 16806604
[TBL] [Abstract][Full Text] [Related]
4. Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
Bessa J; Schmitz N; Hinton HJ; Schwarz K; Jegerlehner A; Bachmann MF
Eur J Immunol; 2008 Jan; 38(1):114-26. PubMed ID: 18081037
[TBL] [Abstract][Full Text] [Related]
5. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
6. The in vivo elimination of CD4+ T cells prevents the induction but not the expression of carrier-induced epitopic suppression.
Leclerc C; Schutze MP; Deriaud E; Przewlocki G
J Immunol; 1990 Sep; 145(5):1343-9. PubMed ID: 1696595
[TBL] [Abstract][Full Text] [Related]
7. Carrier-induced epitopic suppression is initiated through clonal dominance.
Schutze MP; Deriaud E; Przewlocki G; LeClerc C
J Immunol; 1989 Apr; 142(8):2635-40. PubMed ID: 2467933
[TBL] [Abstract][Full Text] [Related]
8. Humoral immune responses to a protective peptide-conjugate against measles after different prime-boost regimens.
Pütz MM; Ammerlaan W; Schneider F; Jung G; Muller CP
Vaccine; 2004 Oct; 22(31-32):4173-82. PubMed ID: 15474707
[TBL] [Abstract][Full Text] [Related]
9. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.
Liu XS; Abdul-Jabbar I; Qi YM; Frazer IH; Zhou J
Virology; 1998 Dec; 252(1):39-45. PubMed ID: 9875315
[TBL] [Abstract][Full Text] [Related]
11. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
[TBL] [Abstract][Full Text] [Related]
12. Effects of pre-existing anti-carrier immunity and antigenic element multiplicity on efficacy of a modular virus-like particle vaccine.
Chuan YP; Rivera-Hernandez T; Wibowo N; Connors NK; Wu Y; Hughes FK; Lua LH; Middelberg AP
Biotechnol Bioeng; 2013 Sep; 110(9):2343-51. PubMed ID: 23532896
[TBL] [Abstract][Full Text] [Related]
13. Bypass of carrier-induced epitope-specific suppression using a T-helper epitope.
Sad S; Rao K; Arora R; Talwar GP; Raghupathy R
Immunology; 1992 Aug; 76(4):599-603. PubMed ID: 1383134
[TBL] [Abstract][Full Text] [Related]
14. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge.
Chung YC; Ho MS; Wu JC; Chen WJ; Huang JH; Chou ST; Hu YC
Vaccine; 2008 Mar; 26(15):1855-62. PubMed ID: 18329759
[TBL] [Abstract][Full Text] [Related]
15. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
[TBL] [Abstract][Full Text] [Related]
16. Effect of P64k presensitization on its efficacy as an immunological carrier in mice.
González S; Caballero E; Silva R; Pajón R
Biochem Biophys Res Commun; 2001 Mar; 282(2):376-9. PubMed ID: 11401468
[TBL] [Abstract][Full Text] [Related]
17. Carrier-induced epitope-specific regulation and its bypass in a protein-protein conjugate.
Kaliyaperumal A; Chauhan VS; Talwar GP; Raghupathy R
Eur J Immunol; 1995 Dec; 25(12):3375-80. PubMed ID: 8566026
[TBL] [Abstract][Full Text] [Related]
18. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
19. Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV).
Mihailova M; Boos M; Petrovskis I; Ose V; Skrastina D; Fiedler M; Sominskaya I; Ross S; Pumpens P; Roggendorf M; Viazov S
Vaccine; 2006 May; 24(20):4369-77. PubMed ID: 16574285
[TBL] [Abstract][Full Text] [Related]
20. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
